ESSA Pharma Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021	FY2020 12 months to Sep 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the year
Items not affecting cash and cash equivalents:
Amortization of right-of-use asset
Accretion of premiums/discounts on short-term investments, net
Accretion of lease liability
Derivative liability gain
Income tax expense
Income tax recovery
Interest income
Finance expense
Accrued investment income
Unrealized foreign exchange
Share-based payments

Changes in non-cash working capital items:
Receivables
Prepaids
Accounts payable and accrued liabilities
Income tax payable
Operating lease liabilities

Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Deposits
Purchase of short-term investments
Proceeds from short-term investments sold
Interest from short-term investments
Net cash provided by (used in) investing activities

CASH FLOWS FROM FINANCING ACTIVITIES
Cash acquired on acquisition of Realm
Transaction costs on acquisition of Realm
Termination costs on Realm sublease
Proceeds on issuance of common shares
Share issuance costs
Options exercised
Warrants exercised
Shares purchased through employee share purchase plan
Lease payments
Loan principal repaid
Loan final payment paid
Interest and financing costs paid
Net cash provided by (used in) financing activities

Effect of foreign exchange on cash and cash equivalents
Change in cash and cash equivalents for the year
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental disclosure of non-cash investing and finance items:
Leased assets obtained in exchange for operating lease liabilities

Comments